ASX - By Stock
|
MCT |
Re:
Ann: Yundamindra Investor Presentation
|
|
volvoman
|
41 |
9.8K |
5 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
41
|
9.8K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Presentation
|
|
volvoman
|
91 |
22K |
13 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
91
|
22K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Proposed issue of securities - PAA
|
|
volvoman
|
15 |
3.0K |
4 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
15
|
3.0K
|
4
|
|
ASX - By Stock
|
BOQ |
Re:
General Discussion
|
|
volvoman
|
312 |
182K |
2 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
312
|
182K
|
2
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Yundamindra Investor Presentation
|
|
volvoman
|
41 |
9.8K |
3 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
41
|
9.8K
|
3
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
43K
|
21M
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
volvoman
|
159 |
37K |
14 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
37K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FIH Data Confirms Optimal Valve Positioning with ComASUR
|
|
volvoman
|
14 |
4.9K |
9 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
14
|
4.9K
|
9
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
43K
|
21M
|
1
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
5 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
43K
|
21M
|
5
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
20 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
43K
|
21M
|
20
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
volvoman
|
331 |
147K |
4 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
331
|
147K
|
4
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
22 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
43K
|
21M
|
22
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
5 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
43K
|
21M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
9.9K |
2.9M |
1 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
9.9K |
2.9M |
2 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
2
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Yundamindra Investor Presentation
|
|
volvoman
|
41 |
9.8K |
4 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
41
|
9.8K
|
4
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
volvoman
|
331 |
147K |
2 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
331
|
147K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
0 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
45
|
11K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
2 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
45
|
11K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
6 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
45
|
11K
|
6
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
volvoman
|
331 |
147K |
19 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
331
|
147K
|
19
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
volvoman
|
331 |
147K |
6 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
331
|
147K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
45
|
11K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
4 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
45
|
11K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
18 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
45
|
11K
|
18
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
2 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
43K
|
21M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
volvoman
|
671 |
236K |
8 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
671
|
236K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
volvoman
|
87 |
32K |
6 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
87
|
32K
|
6
|
|
ASX - By Stock
|
BOQ |
Re:
General Discussion
|
|
volvoman
|
312 |
182K |
4 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
312
|
182K
|
4
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Yundamindra Investor Presentation
|
|
volvoman
|
41 |
9.8K |
7 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
41
|
9.8K
|
7
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
1 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
43K
|
21M
|
1
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
13 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
43K
|
21M
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
volvoman
|
206 |
52K |
8 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
206
|
52K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
volvoman
|
206 |
52K |
14 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
206
|
52K
|
14
|
|
ASX - By Stock
|
PLS |
Re:
PLS chart
|
|
volvoman
|
22K |
10M |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
22K
|
10M
|
0
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Yundamindra Investor Presentation
|
|
volvoman
|
41 |
9.8K |
8 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
41
|
9.8K
|
8
|
|
ASX - By Stock
|
1MC |
Re:
Ann: Consolidation/Split - 1MC
|
|
volvoman
|
64 |
32K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
64
|
32K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
volvoman
|
85 |
21K |
26 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
21K
|
26
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
volvoman
|
620 |
151K |
19 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
620
|
151K
|
19
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman and CEO Presentation
|
|
volvoman
|
43 |
15K |
1 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
43
|
15K
|
1
|
|
ASX - By Stock
|
AVZ |
Re:
Letter from Automic
|
|
volvoman
|
31 |
20K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
31
|
20K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
volvoman
|
620 |
151K |
13 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
620
|
151K
|
13
|
|
ASX - By Stock
|
BOQ |
Re:
Ann: 2024 Half Year Results Announcement
|
|
volvoman
|
37 |
19K |
11 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
37
|
19K
|
11
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
volvoman
|
82K |
49M |
2 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
82K
|
49M
|
2
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
volvoman
|
82K |
49M |
8 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
82K
|
49M
|
8
|
|
ASX - By Stock
|
BOQ |
Re:
Ann: 2024 Half Year Results Announcement
|
|
volvoman
|
37 |
19K |
5 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
37
|
19K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
9.9K |
2.9M |
6 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
9.9K |
2.9M |
9 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
9
|
|
ASX - By Stock
|
BOQ |
Re:
Ann: 2024 Half Year Results Announcement
|
|
volvoman
|
37 |
19K |
6 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
37
|
19K
|
6
|
|